You are here

Phases

×

Error message

Notice: Undefined index: disabled_javascripts in eu_cookie_compliance_page_build() (line 306 of /home/ferdsq/domains/lirh.it/public_html/sites/all/modules/eu_cookie_compliance/eu_cookie_compliance.module).

No drug can become available for the market, without having got evidence that

  • it is safe

  • it improves patients health condition

These can be proven after several steps, developed over a 7-10 years period of time

 

PRECLINICAL RESEARCH

Studies are conducted in laboratories
They are  in vitro (on cells) or in vivo (on animals) studies

CLINICAL RESEARCH

Studies are conducted on patients

Phase I studies evaluate drug safety and tolerability  

Phase II studies evaluate therapeutic potential and dosage of the drug on a few number of patients

Phase III studies evaluate therapeutic potential, efficacy and side effects of the drug on a high number of patients

Phase IV studies evaluate possible side effect, after the new drug become available to the market

 

 

 

 

Codice Fiscale 90026220948 -  P. Iva 00907370944
Iscrizione al n.88 del Registro delle Persone Guridiche della Prefettura di Isernia.

Copyright © 2017 Fondazione Lega Italiana Ricerca Huntington